Veru Inc. ( VERU) - Stock Earnings
VERU Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 1.5 million USD | 247064 USD |
| 2025Q4 | -5.3 million USD | — USD |
| 2026Q1 | -2.7 million USD | 56386 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
VERU Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -93.2 million USD | 16.3 million USD |
| 2024 | -37.8 million USD | 16.9 million USD |
| 2025 | -22.7 million USD | — USD |
| 2026 Est. | — | — |
VERU
Price: $2.95
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.1 million
Ebitda: -7.3 millionMarket Capitalization: 54.6 million